Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CXCL12 G801A polymorphism is a risk factor for sporadic prostate cancer susceptibility.

Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Sept 2007

Hirata Hiroshi, Hinoda Yuji, Kikuno Nobuyuki, Kawamoto Ken, Dahiya Angela V, Suehiro Yutaka, Tanaka Yuichiro, Dahiya Rajvir

Abstract excerpt

PURPOSE: The chemokine CXCL12 and its receptor CXCR4 have been found to be associated with cancer metastasis. A single nucleotide polymorphism of CXCL12 G801A has been described and is regarded as a target for cis-acting factor that has the ability to up-regulate CXCL12 expression. Currently, there are no reports investigating the role of CXCL12 G801A polymorphism in prostate cancer (PC). EXPERIMENTAL DESIGN: We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chemokine CXCL12
Share to Chemokines, CXC

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, p53

Share to Lymphatic Metastasis

Share to Polymorphism, Genetic

Share to Prostatic Neoplasms

Share to Risk Factors

Source

Identifiers

PMID: 17785557
DOI: 10.1158/1078-0432.CCR-07-0859

Genes

CXCL12
CXCR4

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CXCL12 G801A polymorphism is a risk factor for sporadic prostate cancer susceptibility.PMID 17785557Read ↗

CXCL12 G801A polymorphism contributes to cancer susceptibility: a meta-analysis.Semantic proximity Read ↗

The G801A polymorphism in the CXCL12 gene and risk of breast carcinoma: evidence from a meta-analysis including 2,931 subjects.Semantic proximity Read ↗

The CXCL12 G801A polymorphism is associated with cancer risk: a meta-analysis.Semantic proximity Read ↗

CXCL12 G801A polymorphism and cancer risk: An updated meta-analysis.Semantic proximity Read ↗

The CXCL12 G801A polymorphism and cancer risk: evidence from 17 case-control studies.Semantic proximity Read ↗

CXCL12 G801A polymorphism and susceptibility to glioma: a case‑control study.Semantic proximity Read ↗

Role of Genetic Polymorphisms in the Development and Prognosis of Sporadic and Familial Prostate Cancer.Semantic proximity Read ↗

CXCR2 +1208 CT genotype may predict earlier clinical stage at diagnosis in patients with prostate cancer.Semantic proximity Read ↗

CXCL12 G801A polymorphism and breast cancer risk: a meta-analysis.Semantic proximity Read ↗

Allelic variants and immunostaining profile in CXCL12/CXCR4 axis: An investigation of association with prognosis in prostate cancer.Semantic proximity Read ↗

Association of the CXCL12 rs1801157 Polymorphism with Breast Cancer Risk: A Meta-Analysis.Semantic proximity Read ↗

Association between interleukin-8 rs4073 polymorphism and prostate cancer: A meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.